Sign in
4

Changes in Ownership

Immunome Inc. Filed Acc 0001994071-26-000004

Chief Financial Officer sold 60,000 shares at $18.23 ($1,093,800)

  • Chief Financial Officer acquired 60,000 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

Rosett Max · Chief Financial Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2026-06-15 Exercise or conversion : show line 1 in the form 10b5-1 +60,000 $1.05 $63,000 114,037 D
2026-06-15 Sale : show line 2 in the form 10b5-1 −60,000 $18.23 $1,093,800 54,037 D
Open-market sales · 60,000 sh · avg $18.23 · $1,093,800

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-06-15 Exercise or conversion : show line 3 in the form 10b5-1 Stock Option (right to buy) −60,000 0 D
Loading xslF345X06/form4-06172026_090615.xml…